Madrigal ramps up preparations for commercial launch of resmetirom in NASH
Despite positive clinical trials and funding rounds, Madrigal is expected to require more funding for its launch.
Analyst Comment
New study challenges current age-based colorectal cancer screening guidelines
Roche’s drug Phase II trial results can be promising for lupus nephritis patients
The challenge of rising antibiotic-resistant infections in the UK
Truqap’s first approval is not what AstraZeneca was hoping for
AstraZeneca’s Imfinzi Phase III trial raises trial design questions
Positive Phase III data could help position Ubrelvy in a crowded migraine market
Prostate cancer screening and awareness would save thousands of lives in UK
